Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Intravenous Ascorbic Acid in Combination With Irinotecan Versus Irinotecan Alone for Advanced Colorectal Cancer

NCT01550510 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT01550510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Intravenous Ascorbic Acid in Combination With Irinotecan Versus Irinotecan Alone for Advanced Colorectal Cancer
Lead sponsor
Thomas Jefferson University
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2011
Completion date
February 28, 2015
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv colorectal cancer